Thrombotic microangiopathy: Difference between revisions
No edit summary |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
| (4 intermediate revisions by one other user not shown) | |||
| Line 16: | Line 16: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Thrombotic microangiopathies''' are a category of pathologies that result in [[thrombosis]] in [[capillaries]] and [[arterioles]].<ref>{{DorlandsDict|five/000066226|thrombotic microangiopathy}}</ref> This process leads to [[thrombocytopenia]] and a variety of other symptoms such as: [[anemia]], [[purpura]], renal failure (some), | '''Thrombotic microangiopathies''' are a category of pathologies that result in [[thrombosis]] in [[capillaries]] and [[arterioles]].<ref>{{DorlandsDict|five/000066226|thrombotic microangiopathy}}</ref> This process leads to [[thrombocytopenia]] and a variety of other symptoms such as: [[anemia]], [[purpura]], [[renal failure]] (some), [[schistocyte]]s (fragmented blood cells severed by fibrin products) and ischemic injury to cells. | ||
==Categories== | ==Categories== | ||
| Line 28: | Line 28: | ||
==Presentation== | ==Presentation== | ||
The clinical presentation typically includes: [[fever]], microangiopathic hemolytic anemia (see [[schistocytes]] in a blood smear), [[renal failure]], [[thrombocytopenia]], neurological manifestations. | The clinical presentation typically includes: [[fever]], [[hemolytic anemia|microangiopathic hemolytic anemia]] (see [[schistocytes]] in a blood smear), [[renal failure]], [[thrombocytopenia]], neurological manifestations. | ||
==See also== | ==See also== | ||
| Line 34: | Line 34: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
{{Myeloid hematologic disease}} | {{Myeloid hematologic disease}} | ||
{{Vascular diseases}} | {{Vascular diseases}} | ||
{{Diseases of the musculoskeletal system and connective tissue}} | {{Diseases of the musculoskeletal system and connective tissue}} | ||
[[Category:Histopathology]] | [[Category:Histopathology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 16:54, 20 August 2012
| Thrombotic microangiopathy | |
| ICD-10 | M31.1 |
|---|---|
| ICD-9 | 446.6 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Thrombotic microangiopathies are a category of pathologies that result in thrombosis in capillaries and arterioles.[1] This process leads to thrombocytopenia and a variety of other symptoms such as: anemia, purpura, renal failure (some), schistocytes (fragmented blood cells severed by fibrin products) and ischemic injury to cells.
Categories
Bacterial toxins are the primary cause of one category of thrombotic microangiopathy known as HUS or hemolytic uremic syndrome. The other major category is TTP or thrombotic thrombocytopenic purpura caused by autoimmune or hereditary dysfunctions that activate the coagulation cascade or the complement system.
Some sources group TTP and HUS together[2], while other sources express skepticism about their common pathophysiology.[3]
Presentation
The clinical presentation typically includes: fever, microangiopathic hemolytic anemia (see schistocytes in a blood smear), renal failure, thrombocytopenia, neurological manifestations.
See also
References
Template:Vascular diseases Template:Diseases of the musculoskeletal system and connective tissue